This role is responsible for leading internal research projects towards clinical translation; specifically, you will drive the translation of novel small molecules for renal disease. In this role, you will identify and implement in vitro and in vivo models reflective of human disease based on your deep understanding of disease pathogenesis. You will also identify preclinical biomarkers for their potential use in human studies. You will also identify and validate novel therapeutic targets for clinical translation. In this role, you will select and work closely with contract research organizations and/or collaborators to drive these efforts to completion. You will also interact with cross-disciplinary functions within Research and Development and the broader organization. You should be intellectually curious, a proven problem solver, and readily adaptable to changing scientific priorities. Excellent verbal and written communication skills are required as is the ability to drive a project independently and as a member of a team.
Required Skills
Required Experience
Basic Qualifications:
Ph.D in Cell Biology, Molecular Biology, or related field with 2+ years of expereince
Preferred Qualifications:
Ph.D with 2-5 years experience in pharma/biotech industry
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com.
Akebia is an equal opportunity employer and welcomes all job applicants. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.